Molecular imaging using radioluminescent nanoparticles
Molecular imaging of radioluminescent nanoparticle probes injected into biological tissue is performed by irradiated the tissue with ionizing radiation to induce radioluminescence at optical wavelengths, preferably at predetermined near infrared wavelengths. The optical light is detected and processed to determine a spatial distribution of the probes. The radioluminescent nanoparticles may be inorganic or organic phosphors, scintillators, or quantum dots. Imaging systems realizing this technique include tomographic systems using an x-ray beam to sequentially irradiate selected regions, systems with a radioactive source producing the ionizing radiation from outside the tissue, such as with a beam, or inside the tissue, such as with an endoscope or injected radiopharmaceutical. The optical signals may be detected by a photodetector array external to the tissue, a photodetector integrated with an endoscope or mammographic paddle, integrated into a capsule endoscope, or an array positioned near the biological tissue.
1. A method for molecular imaging comprising:
irradiating a selected region of a biological tissue with ionizing radiation to induce radioluminescence emission of optical light from irradiated molecular probes located in the selected region, wherein the molecular probes preferentially bind to a predetermined biological target within the biological tissue, wherein the molecular probes comprise radioluminescent nanoparticles;
detecting the optical light from the irradiated molecular probes to produce signals;
processing the signals to determine a spatial distribution of the irradiated molecular probes in the biological tissue.
2. The method of claim 1 wherein the radioluminescent nanoparticles comprise inorganic phosphors, scintillators, or quantum dots.
3. The method of claim 1 wherein the radioluminescent nanoparticles comprise organic phosphors, scintillators, or quantum dots.
4. The method of claim 1 wherein the radioluminescent emission of optical light comprises emission at a predetermined near infrared (NIR) wavelength.
5. The method of claim 1 wherein the radioluminescent nanoparticles comprise at least two distinct types of material having distinct predetermined optical emission wavelengths.
6. The method of claim 1 , further comprising injecting a radiopharmaceutical compound into the biological tissue, and wherein the ionizing radiation irradiating the selected region of the biological tissue originates from the injected radiopharmaceutical compound.
7. The method of claim 1 wherein irradiating a selected region of the biological tissue with ionizing radiation comprises scanning the biological tissue with a computer-controlled collimated x-ray beam to select a sequence of distinct selected regions.
8. The method of claim 1 wherein irradiating a selected region of the biological tissue with ionizing radiation comprises positioning an endoscope near the selected region, wherein the endoscope comprises a radioactive material producing the ionizing radiation.
9. The method of claim 8 wherein the endoscope comprises a retractable shield to selectively block the ionizing radiation, and collimators to selectively direct the ionizing radiation.
10. The method of claim 1 wherein the ionizing radiation comprises alpha particles, beta particles (electrons or positrons), electron beams, proton beams, gamma rays, ultraviolet light, or x-ray radiation.
11. The method of claim 1 wherein detecting the optical light from the irradiated molecular probes comprises coupling the optical light through an endoscope from a distal end to a photodetector at a proximal end.
12. The method of claim 1 wherein detecting the optical light from the irradiated molecular probes is performed by photodetectors within a capsule endoscope.
13. The method of claim 1 wherein detecting the optical light from the irradiated molecular probes is performed by an array of photodetectors screened from x-ray interference.
14. The method of claim 1 wherein processing the signals comprises producing an image representative of the spatial distribution of the irradiated molecular probes in the biological tissue.
15. The method of claim 1 wherein processing the signals comprises assessing a presence and concentration of the irradiated molecular probes in the biological tissue.
16. The method of claim 1 wherein processing the signals comprises tomographic reconstruction of the spatial distribution of the irradiated molecular probes in the biological tissue.
17. The method of claim 1 further comprising performing simultaneous x-ray imaging of the biological tissue to produce x-ray imaging data, and performing co-registration of the x-ray imaging data with the spatial distribution of the irradiated molecular probes.